Ad
related to: parkinson's disease and technology journal abbreviation 2
Search results
Results From The WOW.Com Content Network
Parkinson's Disease (journal) Parkinson's Disease. (journal) Parkinson's Disease is an open access medical journal covering Parkinson's disease. It was established in 2009 and is published by Hindawi Publishing Corporation. According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.702. [1]
James Parkinson. Parkinson's disease (PD), or simply Parkinson's, is a neurodegenerative disease of mainly the central nervous system that affects both the motor and non-motor systems of the body. The symptoms usually emerge slowly, and, as the disease progresses, non-motor symptoms become more common. Usual symptoms include tremors, slowness ...
Hoehn and Yahr scale. The Hoehn and Yahr scale is a commonly used system for describing how the symptoms of Parkinson's disease progress. It was originally published in 1967 in the journal Neurology by Margaret Hoehn and Melvin Yahr and included stages 1 through 5. [1] Since then, a modified Hoehn and Yahr scale was proposed with the addition ...
The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. [1] The UPDRS is made up of these sections: [2] Part I: evaluation of mentation, behavior, and mood
Research in Parkinson's disease. The research in Parkinson's disease (also known as clinical trials, medical research, research studies, or clinical studies) refers to any study intended to help answer questions about etiology, diagnostic approaches or new treatments of Parkinson's disease (PD) by studying their effects on human subjects.
Chronic fatigue immune dysfunction syndrome. CFS. Chronic fatigue syndrome. CGBD. Corticobasal ganglionic degeneration. CH. Cluster headache. CHARGE syndrome. Coloboma of the eye, heart defects, atresia of the nasal choanae, retarded growth & or development, genital abnormalities, ear abnormalities.
Levodopa (L-Dopa), a drug used in the treatment of Parkinson's disease, improves parkinsonian symptoms in a small percentage of MSA patients. A recent trial reported that only 1.5% of MSA patients experienced any improvement at all when taking levodopa, their improvement was less than 50%, and even that improvement was a transient effect ...
Parkinson's disease (PD) is a complicated neurodegenerative disease that progresses over time and is marked by bradykinesia, tremor, and stiffness. As the condition worsens, some patients may also experience postural instability. [1] Parkinson's disease (PD) is primarily caused by the gradual degeneration of dopaminergic neurons in the region ...
Ad
related to: parkinson's disease and technology journal abbreviation 2